About
Technology
Issues
FAQ
Links
Official Page
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.